Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-30

Clinical Trial Update: Study With Amitriptylin to Evaluate the Efficacy of Melatonin in Treatment of Migraine [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating melatonin for migraine (in combination with amitriptyline) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)
  • amitriptyline (amitriptyline)

Snippet

Sponsor: Hospital Israelita Albert Einstein | Conditions: Migraine | Phase 3 | Status: COMPLETED